Opportunity Information: Apply for PAR 18 726
The NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional), PAR-18-726, is a National Institutes of Health discretionary grant designed to help institutions build strong, structured career development programs for clinically trained vision scientists. The central goal is to create a pipeline of physician-scientists who are well prepared to become independent investigators, particularly in areas that directly strengthen clinical research in ophthalmology and vision science. By supporting mentored research and professional development in an organized, institutional setting, the program aims to expand the overall community of clinical researchers and increase the number of investigators who can translate emerging discoveries into better patient care.
At its core, this FOA asks applicant institutions to propose creative and innovative institutional training frameworks that combine protected time for research, high-quality mentorship, and a multidisciplinary environment. The intent is to produce researchers who can take advantage of rapid advances across several fields that are reshaping eye and vision research, including ocular genetics, new and emerging therapeutics, bioengineering approaches (such as devices, imaging, and tissue engineering), and bio-behavioral research that connects patient behavior, perception, and outcomes to clinical care. NEI is emphasizing contemporary, cross-cutting expertise, reflecting the reality that modern clinical research often requires teams and training that span multiple disciplines, methods, and technologies.
A notable feature of this K12 is its “Clinical Trial Optional” structure. Scholars appointed under the program are allowed to gain clinical trial experience in specific ways that fit a mentored career development plan. In particular, Scholars may propose a separate ancillary study linked to an existing clinical trial, or they may propose to gain experience by working within a clinical trial led by another investigator. This design encourages meaningful exposure to clinical trial operations and scientific questions without requiring a Scholar to independently run a full-scale, high-risk interventional trial early in their career.
However, there are clear boundaries around the types of clinical trials that can be supported. If an application includes research that meets the NIH definition of a clinical trial, it must also fit NIH requirements for either a mechanistic trial or a minimal risk trial. Mechanistic trials focus on understanding biological or behavioral processes, disease pathophysiology, or how an intervention works (for example, studying biomarkers or physiological responses that explain treatment effects). Minimal risk trials are limited to studies where the likelihood and magnitude of harm or discomfort are no greater than what people ordinarily encounter in daily life or during routine physical or psychological examinations or tests. Programs proposing clinical trials that are not mechanistic and/or that involve more than minimal risk are not supported under this FOA. Because the human subjects and clinical trial rules can be nuanced, NEI strongly encourages applicants to consult program staff before submitting an application that involves human subjects research, to confirm alignment with these requirements.
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status) other than institutions of higher education; for-profit organizations other than small businesses; small businesses; federally recognized Native American tribal governments; and Native American tribal organizations other than federally recognized tribal governments. The FOA also highlights additional eligible categories such as Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, non-U.S. entities are not eligible to apply, and non-domestic components of U.S. organizations are not eligible.
Administratively, the opportunity is offered by NIH under the health funding activity category, with CFDA number 93.867, and uses the grant funding instrument. The original closing date listed in the source information is June 11, 2020, and the FOA creation date is March 28, 2018. The summary information provided does not specify an award ceiling or expected number of awards, so those details would typically need to be confirmed in the full FOA or related NIH notices.
Overall, this K12 mechanism is aimed at strengthening the physician-scientist workforce in vision research by funding institutional programs that provide mentored, structured career development, encourage multidisciplinary training aligned with modern scientific advances, and allow appropriately scoped clinical trial experience limited to mechanistic or minimal-risk studies.Apply for PAR 18 726
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.867.
- This funding opportunity was created on 2018-03-28.
- Applicants must submit their applications by 2020-06-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) (PAR-18-726)
What is the NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional), PAR-18-726?
It is a National Institutes of Health (NIH) discretionary grant from the National Eye Institute (NEI) that supports institutions in building structured career development programs for clinically trained vision scientists. The award is designed to create a pipeline of physician-scientists who can become independent investigators in ophthalmology and vision science, with an emphasis on strengthening clinical research.
What is the main goal of this K12 program?
The central goal is to help institutions develop organized, mentored programs that expand the community of clinical researchers and increase the number of investigators who can translate new discoveries into improved patient care in ophthalmology and vision science.
Who applies for this opportunity: individuals or institutions?
Institutions apply. The program is intended to support an institutional career development framework that appoints and mentors Scholars within that structured program.
What kinds of career development activities does the FOA expect institutions to provide?
The FOA emphasizes a structured framework that includes protected time for research, high-quality mentorship, professional development, and a multidisciplinary environment. The intent is to train clinically trained investigators in a way that aligns with modern, team-based clinical research.
What scientific areas does NEI highlight as important for training and research?
The FOA specifically points to several fast-moving areas reshaping eye and vision research, including ocular genetics, new and emerging therapeutics, bioengineering approaches (such as devices, imaging, and tissue engineering), and bio-behavioral research that links patient behavior, perception, and outcomes to clinical care.
Why does the FOA emphasize multidisciplinary training?
The FOA reflects that modern clinical research often requires cross-cutting expertise across disciplines, methods, and technologies. The program is intended to prepare Scholars to work effectively in these multidisciplinary settings.
What does "Clinical Trial Optional" mean in this FOA?
It means Scholars appointed under the program may gain clinical trial experience as part of a mentored career development plan, but they are not required to independently lead a full-scale clinical trial early in their careers.
What types of clinical trial experience are permitted for Scholars?
The FOA describes two allowed approaches: (1) proposing a separate ancillary study linked to an existing clinical trial, or (2) gaining experience by working within a clinical trial led by another investigator.
Are there limits on the kinds of clinical trials that can be included?
Yes. If the research in an application meets the NIH definition of a clinical trial, it must fit NIH requirements for either a mechanistic trial or a minimal risk trial. Clinical trials that are not mechanistic and/or involve more than minimal risk are not supported under this FOA.
What is a mechanistic clinical trial in the context of this FOA?
Mechanistic trials focus on understanding biological or behavioral processes, disease pathophysiology, or how an intervention works. Examples given include studies of biomarkers or physiological responses that explain treatment effects.
What is a minimal risk clinical trial in the context of this FOA?
Minimal risk trials are limited to studies where the likelihood and magnitude of harm or discomfort are no greater than what people ordinarily encounter in daily life or during routine physical or psychological exams or tests.
Can this FOA support interventional clinical trials that are more than minimal risk?
No. The FOA states that programs proposing clinical trials that are not mechanistic and/or that involve more than minimal risk are not supported.
What should applicants do if they are unsure whether their human subjects or clinical trial plans fit the FOA?
NEI strongly encourages applicants to consult program staff before submitting an application that involves human subjects research to confirm alignment with NIH and FOA requirements.
What types of organizations are eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status) other than institutions of higher education; for-profit organizations other than small businesses; small businesses; federally recognized Native American tribal governments; and Native American tribal organizations other than federally recognized tribal governments.
Does the FOA identify any additional eligible applicant categories?
Yes. It highlights categories including Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
Are non-U.S. organizations eligible to apply?
No. Non-U.S. entities are not eligible to apply.
Are non-domestic components of U.S. organizations eligible?
No. The FOA states that non-domestic components of U.S. organizations are not eligible.
What is the funding activity category and CFDA number?
The opportunity is offered under the health funding activity category, and the CFDA number listed is 93.867.
What funding instrument is used?
The funding instrument is a grant.
What is the FOA creation date and the closing date listed in the summary?
The FOA creation date listed is March 28, 2018, and the original closing date shown in the provided summary information is June 11, 2020.
Does the provided summary list an award ceiling or expected number of awards?
No. The summary information provided does not specify an award ceiling or an expected number of awards; those details would typically be confirmed in the full FOA or related NIH notices.
How does this FOA aim to impact patient care?
By strengthening institutional training and mentored research for clinically trained vision scientists, the program aims to increase the number of investigators able to translate emerging discoveries into better clinical care for patients.
Browse more opportunities from the same category: Health
Next opportunity: Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
Previous opportunity: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 726
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 726) also looked into and applied for these:
| Funding Opportunity |
|---|
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed) Apply for PAR 18 721 Funding Number: PAR 18 721 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) Apply for PA 18 724 Funding Number: PA 18 724 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) Apply for PA 18 718 Funding Number: PA 18 718 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) Apply for PA 18 719 Funding Number: PA 18 719 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) Apply for PAR 18 735 Funding Number: PAR 18 735 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional) Apply for PAR 18 736 Funding Number: PAR 18 736 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) Apply for PAR 18 737 Funding Number: PAR 18 737 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 011 Funding Number: RFA RM 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 Clinical Trial Not Allowed) Apply for RFA RM 18 006 Funding Number: RFA RM 18 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) Apply for RFA AR 19 007 Funding Number: RFA AR 19 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) Apply for RFA AR 19 006 Funding Number: RFA AR 19 006 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Impact of Initial Influenza Exposure on Immunity in Infants (U01 Clinical Trial Not Allowed) Apply for RFA AI 18 010 Funding Number: RFA AI 18 010 Agency: National Institutes of Health Category: Health Funding Amount: $3,100,000 |
| Making Health care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18) Apply for PA 18 750 Funding Number: PA 18 750 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Examining Diversity, Recruitment and Retention in Aging Research (R24 Clinical Trial Not Allowed) Apply for PAR 18 749 Funding Number: PAR 18 749 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) Apply for PA 18 753 Funding Number: PA 18 753 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Next-Generation Biologics for Sustained HIV Remission (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 017 Funding Number: RFA AI 18 017 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) Apply for PA 18 754 Funding Number: PA 18 754 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) Apply for PAR 18 755 Funding Number: PAR 18 755 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Curricular or Training Activities in Skills Development (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 759 Funding Number: PA 18 759 Agency: National Institutes of Health Category: Health Funding Amount: $80,000 |
| Development of Curricular or Training Activities in Laboratory Safety (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 758 Funding Number: PA 18 758 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 726", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
